A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects

Clinical trial NCT02140125 · COMPLETED

Trial details

NCT number: NCT02140125
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Pharmacokinetics of ASP2408

Start date: 2012-08-01
Primary completion: 2013-10-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.